GlassScriptPhysician profile
Amy Tank
NPI 1043631831
$8,261.09
in general payments reported to CMS, 2019-2025
34 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $830 · 2022: $1,233 · 2023: $1,440 · 2024: $2,087 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,999 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,998.86 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,037.18 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $931.34 | 2021-2025 | Winlevi, Absorica Ld, Blu-U |
| Janssen Biotech, INC. | $814.35 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Incyte Corporation | $726.10 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $721.67 | 2023-2025 | Sotyktu |
| Lilly USA, LLC | $536.81 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Pfizer INC. | $472.54 | 2021-2025 | |
| Galderma Laboratories, L.P. | $455.33 | 2021-2025 | Aklief, Oracea, Nemluvio |
| Arcutis Biotherapeutics, INC. | $390.62 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $317.84 | 2021-2025 | |
| Amgen INC. | $201.53 | 2022-2025 | Otezla, Otezla |
| Journey Medical Corporation | $170.85 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $167.27 | 2021-2025 | |
| Genzyme Corporation | $157.51 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $151.97 | 2021-2025 | Jublia, Cabtreo, Arazlo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $151.13 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $131.79 | 2021-2025 | Libtayo, Dupixent |
| Almirall LLC | $129.96 | 2021-2025 | Klisyri |
| Leo Pharma INC. | $115.47 | 2021-2025 | Anzupgo, Adbry |
| Vyne Pharmaceuticals INC. | $86.55 | 2021 | |
| Epi Health, LLC | $55.24 | 2022 | |
| Botanix Sb INC | $54.20 | 2025 | Sofdra |
| Biofrontera INC. | $45.54 | 2021-2022 | |
| Strata Skin Sciences, INC. | $40.52 | 2024-2025 | Xtrac |
| Organon LLC | $37.17 | 2025 | |
| Convatec INC. | $23.02 | 2023 | |
| Fidia Pharma USA INC. | $22.44 | 2025 | |
| Organogenesis INC. | $20.36 | 2024 | |
| Verrica Pharmaceuticals INC. | $17.47 | 2023 | Ycanth |
| Mission Pharmacal Company | $17.41 | 2021 | |
| Revance Therapeutics, INC. | $17.33 | 2025 | Daxxify |
| Kyowa Kirin, INC. | $14.94 | 2022 | |
| Lnhc, INC | $14.07 | 2025 | Zelsuvmi |
| Dermavant Sciences, INC. | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Tank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.